Logo image of KIDS

ORTHOPEDIATRICS CORP (KIDS) Stock Fundamental Analysis

NASDAQ:KIDS - Nasdaq - US68752L1008 - Common Stock - Currency: USD

21.4  +0.32 (+1.52%)

After market: 21.82 +0.42 (+1.96%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to KIDS. KIDS was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While KIDS seems to be doing ok healthwise, there are quite some concerns on its profitability. KIDS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year KIDS has reported negative net income.
KIDS had a negative operating cash flow in the past year.
In the past 5 years KIDS reported 4 times negative net income.
In the past 5 years KIDS always reported negative operating cash flow.
KIDS Yearly Net Income VS EBIT VS OCF VS FCFKIDS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

With a decent Return On Assets value of -7.99%, KIDS is doing good in the industry, outperforming 62.96% of the companies in the same industry.
KIDS's Return On Equity of -10.67% is fine compared to the rest of the industry. KIDS outperforms 65.08% of its industry peers.
Industry RankSector Rank
ROA -7.99%
ROE -10.67%
ROIC N/A
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
KIDS Yearly ROA, ROE, ROICKIDS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

With an excellent Gross Margin value of 72.58%, KIDS belongs to the best of the industry, outperforming 83.07% of the companies in the same industry.
In the last couple of years the Gross Margin of KIDS has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for KIDS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
KIDS Yearly Profit, Operating, Gross MarginsKIDS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

KIDS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KIDS has been increased compared to 1 year ago.
The number of shares outstanding for KIDS has been increased compared to 5 years ago.
The debt/assets ratio for KIDS is higher compared to a year ago.
KIDS Yearly Shares OutstandingKIDS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
KIDS Yearly Total Debt VS Total AssetsKIDS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

KIDS has an Altman-Z score of 2.69. This is not the best score and indicates that KIDS is in the grey zone with still only limited risk for bankruptcy at the moment.
KIDS's Altman-Z score of 2.69 is fine compared to the rest of the industry. KIDS outperforms 68.25% of its industry peers.
KIDS has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.21, KIDS is in line with its industry, outperforming 53.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Altman-Z 2.69
ROIC/WACCN/A
WACC8.73%
KIDS Yearly LT Debt VS Equity VS FCFKIDS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

KIDS has a Current Ratio of 6.98. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
KIDS's Current ratio of 6.98 is amongst the best of the industry. KIDS outperforms 85.71% of its industry peers.
KIDS has a Quick Ratio of 3.54. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of KIDS (3.54) is better than 68.25% of its industry peers.
Industry RankSector Rank
Current Ratio 6.98
Quick Ratio 3.54
KIDS Yearly Current Assets VS Current LiabilitesKIDS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for KIDS have decreased strongly by -76.79% in the last year.
The Revenue has grown by 37.65% in the past year. This is a very strong growth!
KIDS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.04% yearly.
EPS 1Y (TTM)-76.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-137.93%
Revenue 1Y (TTM)37.65%
Revenue growth 3Y27.84%
Revenue growth 5Y23.04%
Sales Q2Q%40.02%

3.2 Future

Based on estimates for the next years, KIDS will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.66% on average per year.
KIDS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.18% yearly.
EPS Next Y18.95%
EPS Next 2Y16.1%
EPS Next 3Y15.66%
EPS Next 5YN/A
Revenue Next Year17.61%
Revenue Next 2Y17.33%
Revenue Next 3Y17.18%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
KIDS Yearly Revenue VS EstimatesKIDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
KIDS Yearly EPS VS EstimatesKIDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

KIDS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KIDS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KIDS Price Earnings VS Forward Price EarningsKIDS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KIDS Per share dataKIDS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

KIDS's earnings are expected to grow with 15.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.1%
EPS Next 3Y15.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for KIDS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORTHOPEDIATRICS CORP

NASDAQ:KIDS (5/6/2025, 8:20:35 PM)

After market: 21.82 +0.42 (+1.96%)

21.4

+0.32 (+1.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-04 2025-03-04/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners73.31%
Inst Owner Change0.08%
Ins Owners4%
Ins Owner Change3.2%
Market Cap531.36M
Analysts83.08
Price Target38.32 (79.07%)
Short Float %6.7%
Short Ratio5.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-77.1%
Min EPS beat(2)-115.9%
Max EPS beat(2)-38.31%
EPS beat(4)2
Avg EPS beat(4)-32.43%
Min EPS beat(4)-115.9%
Max EPS beat(4)17.58%
EPS beat(8)5
Avg EPS beat(8)-7.32%
EPS beat(12)7
Avg EPS beat(12)3.23%
EPS beat(16)10
Avg EPS beat(16)10.8%
Revenue beat(2)1
Avg Revenue beat(2)0.38%
Min Revenue beat(2)-0.42%
Max Revenue beat(2)1.19%
Revenue beat(4)2
Avg Revenue beat(4)1.06%
Min Revenue beat(4)-1.39%
Max Revenue beat(4)4.87%
Revenue beat(8)3
Avg Revenue beat(8)0.48%
Revenue beat(12)4
Avg Revenue beat(12)-0.69%
Revenue beat(16)6
Avg Revenue beat(16)-0.15%
PT rev (1m)7.35%
PT rev (3m)-1.65%
EPS NQ rev (1m)-1.48%
EPS NQ rev (3m)-16.03%
EPS NY rev (1m)-2.17%
EPS NY rev (3m)-24.35%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-2.24%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.6
P/FCF N/A
P/OCF N/A
P/B 1.5
P/tB 2.96
EV/EBITDA N/A
EPS(TTM)-1.63
EYN/A
EPS(NY)-1.32
Fwd EYN/A
FCF(TTM)-1.69
FCFYN/A
OCF(TTM)-1.09
OCFYN/A
SpS8.25
BVpS14.28
TBVpS7.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.99%
ROE -10.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.58%
FCFM N/A
ROA(3y)-4.16%
ROA(5y)-5.62%
ROE(3y)-5.3%
ROE(5y)-7.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-0.71%
F-Score3
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 78.14%
Cap/Sales 7.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.98
Quick Ratio 3.54
Altman-Z 2.69
F-Score3
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)87.97%
Cap/Depr(5y)110.98%
Cap/Sales(3y)9.42%
Cap/Sales(5y)12.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-137.93%
EPS Next Y18.95%
EPS Next 2Y16.1%
EPS Next 3Y15.66%
EPS Next 5YN/A
Revenue 1Y (TTM)37.65%
Revenue growth 3Y27.84%
Revenue growth 5Y23.04%
Sales Q2Q%40.02%
Revenue Next Year17.61%
Revenue Next 2Y17.33%
Revenue Next 3Y17.18%
Revenue Next 5YN/A
EBIT growth 1Y-14.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.88%
EBIT Next 3Y49.82%
EBIT Next 5YN/A
FCF growth 1Y8.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.01%
OCF growth 3YN/A
OCF growth 5YN/A